کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8507680 | 1555973 | 2018 | 14 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
داروسازی، سم شناسی و علوم دارویی
اکتشاف دارویی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Both PDE9 inhibitors and PPARγ agonists such as rosiglitazone exhibited remarkable preclinical and clinical treatment effects for Alzheimer's disease and type 2 diabetes mellitus. A series of PDE9 inhibitors combining the pharmacophore of rosiglitazone were discovered. Four of them exhibited excellent inhibitory activity against PDE9A and low cell toxicity. The most effective compound 11a gave the IC50 of 1.0 nmol/L towards PDE9, which was significantly better than the reference compounds PF-04447943 and BAY 73-6691.275
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Acta Pharmaceutica Sinica B - Volume 8, Issue 4, July 2018, Pages 615-628
Journal: Acta Pharmaceutica Sinica B - Volume 8, Issue 4, July 2018, Pages 615-628
نویسندگان
Xu-Nian Wu, Ya-Dan Huang, Jin-Xuan Li, Yan-Fa Yu, Qian Zhou, Chen Zhang, Yinuo Wu, Hai-Bin Luo,